InventaBioTech Inc. (OTCPK:INVB) announced that it has entered into a subscription agreement for private placement on a best efforts basis of unsecured convertible promissory note with Sue Lynn Hui for gross proceeds of $300,000 on January 31, 2019. The note bears an interest rate of 12% per annum. The interest shall be paid in common stock at any time a note holder sends notice of conversion to the company. The note will mature on January 31, 2020. The note holders are entitled to convert all or any amount of principal face amount any accrued but unpaid interest of the notes into common shares at any time at a conversion price of $0.20 per share. The company received net proceeds of $195,041.09 in the transaction. The company has issued securities pursuant to exemption provided under Regulation D.